Recall: D-0506-2026

Class II - Potentially Harmful

Class IIClassification

2026-04-01Initiated

OngoingStatus

Wells Pharma of Houston LLCFirm

Product

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.

Reason

cGMP deviations.

Distribution

U.S. Nationwide.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.